Neoantigen-loaded DC vaccine

DRUG4 trials

Sponsors

The First Affiliated Hospital of Nanchang University

Conditions

Advanced NSCLCColorectal Cancer (CRC)

Phase 2

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

RecruitingNCT06751849

The First Affiliated Hospital of Nanchang UniversityAdvanced NSCLC

Start: 2024-03-11End: 2026-06-10Target: 10Updated: 2024-12-30

Unknown Phase

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

RecruitingNCT06752057

The First Affiliated Hospital of Nanchang UniversityAdvanced NSCLC

Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

RecruitingNCT06751953

The First Affiliated Hospital of Nanchang UniversityColorectal Cancer (CRC)

Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30

Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

RecruitingNCT06751940

The First Affiliated Hospital of Nanchang UniversityColorectal Cancer (CRC)

Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30